News

NanoViricides Opens New Facility in Shelton, CT for Production of Drug Candidates

October 1, 2014 admin 0

NanoViricides, Inc. (NYSE MKT:NNVC) opened its new R&D and cGMP pilot manufacturing facility with U.S. Congressman Jim Himes performing the ribbon cutting to inaugurate the facility on July 21, 2014.

NanoViricides, Inc. is a development stage company that is creating special purpose nanomaterials for viral therapy. The company’s novel nanoviricide® class of drug candidates is designed to specifically attack enveloped virus particles and dismantle them.

The First OneMedMarket Conference

June 11, 2014 admin 0

On May 21, 2014, the first OneMedMarket conference was held in New York City. Accredited investors turned out from all over for presentations from eleven […]

The Whirl of Wound Care

March 29, 2014 Varun Bajaj 0

However irksome it may be to think about open or healing wounds, the medical advances and market potential in this niche space is quite appealing for investors. Globally, there are 50 million reported cases of patients suffering from some type of wound that may be difficult to close or heal.

SpectraScience: Innovations in Cancer Detection

January 4, 2014 OneMedPlace Team 0

SpectraScience has developed patented platform technology that diagnoses colorectal cancer, which has a market size of $1, 442.6 million.

DesignMedix: Overcoming Drug Resistance

January 2, 2014 OneMedPlace Team 0

DesignMedix places great emphasis on tackling problems of drug resistant diseases, such as malaria, bacteria, and cancer.

BioLife Solutions: Powering the Preservation Sciences

December 31, 2013 OneMedPlace Team 0

BioLife Solutions has a strong interest in target markets: regenerative medicine, biobanking, and drug discovery.

Avantis Medical Systems Enters Enormous Endoscope Market

December 30, 2013 OneMedPlace Team 0

Avantis Medical Systems is company that is tapping into large Endoscope market which has 30 million colonoscopies globally and 15 million in the US alone.

International Stem Cell Corporation Progressing in Human Induced Stem Cells

December 13, 2013 OneMedPlace Team 0

International Stem Cell Corporation (OTCQB: ISCO) is a biotechnology company that focuses on developing novel stem cell based therapies. Most recently, they have made significant progress in human induced pluripotent stem cells (iPS) and its derivation with novel protein-based reprogramming method.

Plandai Biotechnology Sets for Battle Against Neurological Diseases by using Nutraceuticals

December 13, 2013 OneMedPlace Team 0

Plandaí Biotechnology, Inc. (OTCQB: PLPL) transforming the world of nutraceuticals by making available extracts from live plant material that deliver the highest levels of bioavailability currently in the market. These extracts are utilized to deliver a new family of drugs to safely and cost effectively treats a plethora of different diseases and conditions.

First-Mover Healthcare CrowdFunding Portals and Online Investment Firms to Present at 7th Annual OneMedForum San Francisco

December 11, 2013 bjohnson56 0

OneMedForum announced today that it has assembled two panels featuring early entrants in the emerging areas of crowdfunding and online investment banking in healthcare. Panelists […]

OneMedPlace | Blog

Just another WordPress site